Effect of early salvage radiotherapy at PSA < 0.5 ng/ml and impact of post-SRT PSA nadir in post-prostatectomy recurrent prostate cancer

被引：0
|
作者：
Dirk Bottke
Detlef Bartkowiak
Alessandra Siegmann
Reinhard Thamm
Dirk Böhmer
Volker Budach
Thomas Wiegel
机构：
[1] Fachbereich Strahlentherapie,MVZ Klinikum Esslingen GmbH
[2] University Hospital Ulm,Department of Radiation Oncology and Radiotherapy
[3] Charité Universitätsmedizin Berlin Campus Benjamin Franklin,Department of Radiation Oncology and Radiotherapy
来源：
Prostate Cancer and Prostatic Diseases | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：344 / 349
页数：5
相关论文
共 50 条
  • [31] [18F]DCFPyL PET/CT in detection and localization of recurrent prostate cancer following prostatectomy including low PSA < 0.5 ng/mL
    Perry, Elisa
    Talwar, Arpit
    Taubman, Kim
    Ng, Michael
    Wong, Lih-Ming
    Booth, Russell
    Sutherland, Tom R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (06) : 2038 - 2046
  • [32] Post-treatment PSA ≤0.2 ng/mL defines disease freedom after radiotherapy for prostate cancer using modern techniques
    Critz, FA
    Williams, WH
    Holladay, CT
    Levinson, AK
    Benton, JB
    Holladay, DA
    Schnell, FJ
    Maxa, LS
    Shrake, PD
    UROLOGY, 1999, 54 (06) : 968 - 971
  • [33] Impact Of 18F-DCFPyL PSMA PET Scans On Standard Contouring Guidelines For Salvage Prostate Bed Radiotherapy For Recurrent Prostate Cancer Post-Prostatectomy
    Kelly, F.
    Ong, G.
    Benson, A.
    Starmans, M.
    Blakey, D. L.
    Foo, M. S.
    Guerrieri, M.
    Chao, M.
    Taubman, K.
    Yap, K.
    Sutherland, T.
    Ng, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E902 - E902
  • [34] Post-radiotherapy two year PSA nadir as a predictor of long-term prostate cancer mortality
    Zelefsky, M. J.
    Yamada, Y.
    Park, J.
    Kollmeier, M.
    Cox, B.
    Venkatraman, E. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S287 - S287
  • [35] EARLY OUTCOME OF VOLUMETRIC MODULATED RAPIDARCTM HYPOFRACTIONATED POST-PROSTATECTOMY RADIOTHERAPY OF PROSTATE CANCER
    Jereczek-Fossa, B. A.
    Zerini, D.
    Bonora, M.
    Fodor, C.
    Fanti, P.
    Mauro, R.
    Bossi-Zanetti, I.
    Caputo, M.
    Vavassori, A.
    Vigorito, S.
    Luraschi, R.
    Comi, S.
    Cattani, F.
    Cambria, R.
    Garibaldi, C.
    De Cobelli, O.
    Orecchia, R.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S380 - S380
  • [36] Salvage radiotherapy (SRT) in combination with pembrolizumab in patients with PSA persistence or biochemical recurrence after radical prostatectomy due to prostate cancer.
    Grabbert, Markus
    Zamboglou, Constantinos
    Josef, Annika
    Sigle, August
    Spohn, Simon K. B.
    Grosu, Anca L.
    Gratzke, Christian
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [37] The diagnostic impact of pro-PSA in the early detection of prostate cancer (PCA) in patients with a total PSA range of 4.0 to 10.0 ng/ml
    Veltri, RW
    Khan, MA
    Rittenhouse, HG
    Mikolajczyk, SD
    Sokoll, LJ
    Chan, DW
    Partin, AW
    JOURNAL OF UROLOGY, 2003, 169 (04): : 384 - 384
  • [38] Prognostic value of PSA nadir ≤4 ng/mL within 4 months of high-dose radiotherapy for locally advanced prostate cancer
    Nickers, Philippe
    Albert, Adelin
    Waltregny, David
    Deneufbourg, Jean-Marie
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (01): : 73 - 77
  • [39] PSA nadir ≤4ng/ml within 4 months after External Radiotherapy and Brachytherapy of prostate cancer as a new indicator for outcome
    Nickers, P
    RADIOTHERAPY AND ONCOLOGY, 2005, 75 : S27 - S27
  • [40] PSA Nadir of &lt;0.5 ng/mL Following Brachytherapy for Early-Stage Prostate Adenocarcinoma is Associated With Freedom From Prostate-Specific Antigen Failure
    Ko, Eric C.
    Stone, Nelson N.
    Stock, Richard G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (02): : 600 - 607
12345